Deals review

Deals review
Deal details

Nabi Biopharmaceuticals Announces Arbitration Settlement With Inhibitex, Inc.

In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.

Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer. Find out more.

Request a demo of
Pharmalicensing Intelligence

Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP

Nabi Biopharmaceuticals Acquires Full Rights to Aloprim™

Nabi Biopharmaceuticals Takes Steps to Expand Market Potential for StaphVAX® Beyond ESRD Patient Population

Nabi Biopharmaceuticals signs international distribution agreement for Nabi-HB(R)

Ligand Pharmaceuticals and the SALK Institute Enter Settlement Agreement and Mutual Release of All Claims

Nabi Biopharmaceuticals Significantly Enhances NicVAX Patent Portfolio

Favorable settlement for Zila in Trylon dispute

Nabi expands global presence

Nabi Biopharmaceuticals Enters Clinical Initiative With US Military to Advance PentaStaph(tm)

Related categories

Therapeutic target

Cardiovascular

Central Nervous System

More deals

Clients in focus...

Get the Flash Player to see this rotator.

Products:	Partnering Search	Company Profiling	Pharmalicensing Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Industrial Sector	Therapeutic Target	Articles date
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	FAQ	Contact us	Site map

Deals review

Nabi Biopharmaceuticals Announces Arbitration Settlement With Inhibitex, Inc.

Related deals

Related categories

More deals

Latest deals

Most viewed deals

By month